[PDF][PDF] Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.

N Petejova, A Martinek - … Papers of the Medical Faculty of …, 2016 - biomed.papers.upol.cz
Methods. A literature search using the databases Medscape, Pubmed, UpToDate and
EBSCO from 1945 to 2015. Results and Conclusions. Genetic predisposition/hereditary …

Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes …

DA Jolliffe, RT Walton, CJ Griffiths… - The Journal of steroid …, 2016 - Elsevier
Polymorphisms in genes encoding proteins involved in vitamin D metabolism and transport
are recognised to influence vitamin D status. Syntheses of genetic association studies …

Vitamin D receptor polymorphisms and cancer

P Gnagnarella, S Raimondi, V Aristarco… - Sunlight, Vitamin D and …, 2020 - Springer
Increasing scientific evidence supports the link between vitamin D and cancer risk. The
active metabolite 1, 25 (OH) 2D exerts its activity by binding to the vitamin D receptor (VDR) …

Vitamin D receptor: a novel therapeutic target for kidney diseases

S Yang, A Li, JW Wang, J Liu, Y Han… - Current Medicinal …, 2018 - ingentaconnect.com
Background: Kidney disease is a serious problem that adversely affects human health, but
critical knowledge is lacking on how to effectively treat established chronic kidney disease …

Vitamin D, cancer risk, and mortality

E Tagliabue, S Raimondi, S Gandini - Advances in food and nutrition …, 2015 - Elsevier
Abstract Antiproliferative effects of 1, 25-dihydroxyvitamin D, the biologically active form of
vitamin D, are well established in various cell types by influencing cell differentiation and …

Vitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches

MI Khan, ZF Bielecka, MZ Najm… - International …, 2014 - spandidos-publications.com
Cancer is a major health problem and cause of death worldwide that accounted for 7.6
million deaths in 2008, which is projected to continue rising with an estimated 13.1 million …

Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis

P Gnagnarella, E Pasquali, D Serrano… - …, 2014 - academic.oup.com
Numerous studies investigated the associations of VDR polymorphisms with various types of
cancer, suggesting an influence on cancer risk. FokI is one of the most frequently analysed …

Unveiling molecular associations of polymorphic variants of VDR gene (FokI, BsmI and ApaI) in multiple myeloma patients of Indian population

R Kumar, N Gupta, V Singh, V Kumar, A Haq… - The Journal of Steroid …, 2020 - Elsevier
Multiple myeloma (MM) is a plasma cell malignancy frequently accompanied with skeletal co-
morbidity. Vitamin D (1, 25 (OH) 2 D) is an important mediator of skeletal homeostasis that …

The vitamin D receptor gene ApaI polymorphism is associated with increased risk of renal cell carcinoma in Chinese population

C Yang, J Li, Y Li, D Wu, C Sui, Y Jiang, F Meng - Scientific reports, 2016 - nature.com
Molecular epidemiologic studies previously reported that 1, 25-dihydroxy vitamin D3 (1, 25
(OH) 2 D3) appears to influence cancer risk. It exerts its activity through the intracellular …

BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysis

S Raimondi, E Pasquali, P Gnagnarella… - Mutation Research …, 2014 - Elsevier
The VDR gene is an important regulator of the vitamin D pathway, and the role of some of its
polymorphisms on cancer risk was previously investigated. A trend of cancer risk reduction …